Headache Relief PM

Product NDC
63941-373
11-digit product format
639410373
Labeler code
63941
Product ID
63941-373_85b1de9f-f40c-4f53-b327-5f1a8a20b112
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen and Diphenhydramine Citrate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Valu Merchandisers Company
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2004-06-07
Marketing end
2020-02-20
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE CITRATE
Active strength
500 mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct63941-373DDiscontinued by firm2026-10-12
excluded packagepackage63941-37363941-373-15DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage63941-373-15d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage63941-373-15f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage63941-373-152ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage63941-373-15a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage63941-373-15cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage63941-373-15cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage63941-373-15302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage63941-373-15ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage63941-373-150efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage63941-373-15ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage63941-373-15367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage63941-373-15557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
DIPHENHYDRAMINE CITRATEACTIVE INGREDIENT4OD433S209HEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
ACETAMINOPHENACTIVE MOIETY362O9ITL9DHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
DIPHENHYDRAMINEACTIVE MOIETY8GTS82S83MHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48HEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
CROSPOVIDONEINACTIVE INGREDIENT68401960MKHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30HEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
POVIDONESINACTIVE INGREDIENTFZ989GH94EHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
SHELLACINACTIVE INGREDIENT46N107B71OHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4HEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPHEADACHE RELIEF PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) TABLET, FILM COATED [VALUE MERCHANDISERS COMPANY, INC.]3